💰The Funding Letter #1244: September 12

Conigital, ImmunityBio, Open Cosmos, and more...

September 12, 2023


Good Morning! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. 🔥New Sales Gigs from Apollo below!

Hit the Gong 🎉

Source: @sales_bant_er

Daily Deals 💸

🌎 Americas

ImmunityBio is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $270M, Post-IPO Equity + $200M, Post-IPO Debt

Round Investors: NantCapital (lead)

🚀Growth Focus: Support its ongoing operations and pre-commercialization activities through the anticipated potential FDA approval of Anktiva for BCG-unresponsive bladder cancer.

HQ: San Diego, CA

Industry: Biotechnology Research

Employee Count: 540

Subscribe to TFL All-Access Tier to read the rest.

Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
  • • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
  • • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
  • • ..and much more to come!